
    
      A Phase III, Randomized, Multicentre, Double-blind, Double-dummy, Parallel-group Comparative
      Study to Determine the Efficacy, Safety And Tolerability of Ceftazidime-Avibactam Versus
      Meropenem in the Treatment of Nosocomial Pneumonia Including Ventilator-Associated Pneumonia
      in Hospitalized Adults
    
  